全文获取类型
收费全文 | 5140篇 |
免费 | 266篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 362篇 |
妇产科学 | 88篇 |
基础医学 | 438篇 |
口腔科学 | 180篇 |
临床医学 | 323篇 |
内科学 | 1135篇 |
皮肤病学 | 268篇 |
神经病学 | 294篇 |
特种医学 | 125篇 |
外科学 | 741篇 |
综合类 | 186篇 |
预防医学 | 249篇 |
眼科学 | 308篇 |
药学 | 436篇 |
中国医学 | 13篇 |
肿瘤学 | 239篇 |
出版年
2023年 | 38篇 |
2022年 | 76篇 |
2021年 | 169篇 |
2020年 | 75篇 |
2019年 | 152篇 |
2018年 | 188篇 |
2017年 | 130篇 |
2016年 | 157篇 |
2015年 | 165篇 |
2014年 | 211篇 |
2013年 | 224篇 |
2012年 | 385篇 |
2011年 | 447篇 |
2010年 | 233篇 |
2009年 | 178篇 |
2008年 | 246篇 |
2007年 | 285篇 |
2006年 | 208篇 |
2005年 | 196篇 |
2004年 | 171篇 |
2003年 | 144篇 |
2002年 | 161篇 |
2001年 | 111篇 |
2000年 | 121篇 |
1999年 | 90篇 |
1998年 | 41篇 |
1997年 | 19篇 |
1996年 | 20篇 |
1995年 | 35篇 |
1994年 | 17篇 |
1992年 | 69篇 |
1991年 | 64篇 |
1990年 | 41篇 |
1989年 | 37篇 |
1988年 | 54篇 |
1987年 | 39篇 |
1986年 | 32篇 |
1985年 | 38篇 |
1984年 | 27篇 |
1983年 | 23篇 |
1979年 | 22篇 |
1977年 | 15篇 |
1975年 | 16篇 |
1974年 | 26篇 |
1973年 | 15篇 |
1972年 | 27篇 |
1971年 | 19篇 |
1970年 | 15篇 |
1969年 | 16篇 |
1968年 | 18篇 |
排序方式: 共有5416条查询结果,搜索用时 15 毫秒
61.
Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. 总被引:26,自引:0,他引:26
Hesperidin, a bioflavonoid, is an abundant and inexpensive by-product of Citrus cultivation. A deficiency of this substance in the diet has been linked with abnormal capillary leakiness as well as pain in the extremities causing aches, weakness and night leg cramps. No signs of toxicity have been observed with the normal intake of hesperidin or related compounds. Both hesperidin and its aglycone hesperetin have been reported to possess a wide range of pharmacological properties. This paper reviews various aspects of hesperidin and its related compounds, including their occurrence, physical and chemical properties, analysis, pharmacokinetics, safety and toxicity and the marketed products available. A special emphasis has been laid on the pharmacological properties and medicinal uses of these compounds. 相似文献
62.
Glycyrrhetinic acid-modified chitosan (mGA-suc-CTS) is used as liver-targeted carrier for drug delivery. In this study, nanoparticles were prepared by ionic gelation process, and glycyrrhetinic acid act as the targeting ligand. The structure of the product was confirmed by IR and NMR techniques. The main aim of this study was to deliver atorvastatin directly to the liver by using same conjugate and reduce the associated side-effects, i.e. hepatotoxicity at high dose. Characterization of the developed formulation was performed by differential scanning calorimetry, particle size measurements and cellular uptake studies. Release profile, pharmacokinetics studies and organ distribution studies showed that developed formulation shows a relative higher liver uptake. The optimized formulation showed increased plasma concentration than the CTS nanoparticles as well as plain drug and the accumulation in the liver was nearly 2.59 times more than that of obtained with the CTS nanoparticles. Pharmaceutical and pharmacological indicators suggested that the proposed strategy can be successfully utilized for liver targeting of therapeutics. 相似文献
63.
Van C Lansingh Ravilla D Ravindran Prashant Garg Merle Fernandes Akshay Gopinathan Nair Parikshit J Gogate Sundaram Natarajan Meenakshi Swaminathan Ashish E Bachhav Rashmin A Gandhi 《Indian journal of ophthalmology》2022,70(11):4079
While ophthalmology as a surgical branch itself has evolved technologically with newer instruments, techniques and procedures; ophthalmic surgical training appears to have stagnated in terms of how it is delivered and how trainees’ learning and performance are assessed. This collaborative editorial attempts to identify the lacunae in ophthalmic residency training and highlight how technological tools such as surgical simulators can be incorporated into ophthalmic training even in limited-resource settings with good results. 相似文献
64.
C R Vishwaraj Srinivasan Kavitha Rengaraj Venkatesh Aakriti Garg Shukla Premanand Chandran Shweta Tripathi 《Indian journal of ophthalmology》2022,70(2):380
Neuroprotective therapies in glaucoma may play a role in preventing ischemia and oxidative damage that results in apoptosis of retinal ganglion cells and optic nerve damage. Although intraocular pressure (IOP) is the only known modifiable risk factor for glaucoma, disease progression commonly occurs despite IOP control, suggesting that factors other than IOP play a role in its pathogenesis and can potentially act as targets for neuroprotection. Factors including mediators of apoptosis, ischemic changes, poor ocular blood flow and neurotoxins have been hypothesized to play a role in glaucoma progression. Neuroprotective targets include glutamate-induced neurotoxicity, nitric oxidase synthetase, neurotropins, calcium channel receptors, free radicals, vascular insufficiency, the rho-kinase pathway, and more. Drugs related to these factors are being evaluated for their role in neuroprotection, although this area of investigation faces several challenges including limited evidence for these agents’ efficacy in clinical studies. Additionally, while IOP-lowering therapies are considered neuroprotective as they generally slow the progress of glaucoma progression, they are limited by the extent of their effect beyond IOP control. The aim of this article is to review the current treatment options available for neuroprotection and to explore the drugs in the pipeline. 相似文献
65.
66.
67.
68.
Vaidehi Garg Jayabalan Nirmal Yassine Riadi Prashant Kesharwani Kanchan Kohli Gaurav Kumar Jain 《Journal of pharmaceutical sciences》2021,110(2):871-875
This work was aimed to improve the efficacy of tacrolimus in the treatment of endotoxin-induced uveitis (EIU) using propylene glycol modified lipid vesicles termed as proglycosome nano-vesicles (PNVs). PNVs were prepared by modified film hydration method. Experimental uveitis in rabbit eye was induced by an intravitreal injection of 20 μL of the endotoxin solution containing 100 ng of lipopolysaccharide endotoxin. In vivo efficacy of PNVs was determined by studying clinical symptoms of uveitis using slit lamp examination and by quantitatively measuring levels of tumor necrosis factor-alpha, interleukin-6, leukocytes and total proteins in aqueous humor, 24 h after intravitreal injection of endotoxin. Comparison was made with healthy, untreated and tacrolimus solution treated eyes. PNVs developed were nano-sized, deformable and showed sustained release of tacrolimus over period of 12 h. In vivo results indicated statistically significant difference between the effects of PNVs in the treatment of EIU compared to tacrolimus. PNV treatment not only subsides clinical symptoms of uveitis but also prevented breakdown of blood aqueous barrier. Tacrolimus loaded PNVs are potential new topical treatment for uveitis. 相似文献
69.
70.